Observational study finds low eGFR linked to increased kidney failure risk — Evidence Review
Published in Kidney International, by researchers from Karolinska Institutet
Researched by
— the AI search engine for science
Table of Contents
A new large-scale study finds that normal kidney test results may still indicate elevated risk for chronic kidney disease, challenging current clinical assumptions. Most related research supports the link between lower percentile kidney function—even within the "normal" range—and increased risk for kidney failure and adverse outcomes, reinforcing the significance of these findings from Karolinska Institutet.
- Several meta-analyses and cohort studies have demonstrated that lower estimated glomerular filtration rate (eGFR) values, even those within standard reference ranges, are associated with higher risks of kidney failure, cardiovascular events, and mortality 2 11.
- Research supports the need for enhanced screening and risk assessment strategies, as current measures may not adequately capture early risk in individuals with eGFR values considered "normal" but low for their age and sex 2 4 6.
- Existing literature highlights the importance of combining eGFR with additional markers such as albuminuria to improve early detection and risk stratification for chronic kidney disease 2 4 11.
Study Overview and Key Findings
Chronic kidney disease (CKD) is a growing public health concern, with many individuals remaining undiagnosed until significant loss of kidney function has occurred. This new study, conducted by researchers at Karolinska Institutet and published in Kidney International, addresses the challenge of early CKD detection by examining kidney function within a large population cohort. The study introduced age- and sex-specific eGFR reference charts and a web-based tool intended to help clinicians identify risk even when test results appear normal. By leveraging a vast dataset, the research underscores that small decrements in kidney function—still within the "normal" range—may signal increased risk for progression to kidney failure.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Karolinska Institutet |
| Journal Name | Kidney International |
| Authors | Yuanhang Yang, Antoine Creon, Andrew S. Levey, Anne-Laure Faucon, Aurora Caldinelli, Marie Evans, Arvid Sjölander, Alberto Ortiz, Edouard L. Fu, Juan Jesus Carrero |
| Population | Adults in the Stockholm region of Sweden |
| Sample Size | n=1.1 million |
| Methods | Observational Study |
| Outcome | Kidney function levels and associated health outcomes |
| Results | eGFR below the 25th percentile linked to higher kidney failure risk |
Literature Review: Related Studies
To situate these findings within the broader scientific context, we searched the Consensus paper database, containing over 200 million research papers. The following search queries were used to identify relevant studies:
Summary Table of Key Topics and Findings
| Topic | Key Findings |
|---|---|
| How does eGFR within the "normal" range relate to future disease risk? | - Lower eGFR values, even within the normal range, are associated with increased risk for kidney failure, adverse outcomes, and mortality 2 11. - eGFR percentiles provide additional prognostic information beyond absolute cut-offs, suggesting that relative kidney function matters for risk stratification 2 4. |
| Are current kidney function tests and equations accurate for early risk detection? | - Standard eGFR equations have limitations in detecting early-stage CKD or in patients with normal serum creatinine; measured GFR may provide better accuracy 6 8 10. - Adjustments to eGFR equations, such as removing race coefficients, can shift risk categorization without compromising predictive value 5. |
| What is the value of combining eGFR with other markers for risk prediction? | - Albuminuria, when combined with eGFR, improves the prediction of kidney failure and related adverse outcomes 2 4 11. - Risk equations that include age, sex, albuminuria, and eGFR, such as the Kidney Failure Risk Equation (KFRE), enhance clinical decision-making 4. |
| How do changes in kidney function over time inform prognosis? | - eGFR slope (rate of decline) is a useful predictor of renal and cardiovascular outcomes, particularly in high-risk groups like those with diabetes 1 13. - Serial measurements and risk modeling can aid early identification of patients likely to progress to kidney failure 3 13. |
How does eGFR within the "normal" range relate to future disease risk?
Recent large-scale studies and meta-analyses have consistently shown that individuals with eGFR values at the lower end of the normal distribution face a higher risk of kidney failure, cardiovascular events, and mortality. The new study aligns with this evidence, emphasizing that percentile-based assessment of eGFR can uncover risk that absolute thresholds may miss.
- Lower eGFR—even within standard reference ranges—correlates with increased risk for adverse kidney and cardiovascular outcomes 2 11.
- Meta-analyses demonstrate a graded, exponential increase in risk as eGFR values decline below average for age and sex 2 11.
- The new study's percentile-based approach is supported by evidence that relative kidney function provides prognostic value beyond fixed cut-offs 2 4.
- The findings encourage clinicians to look beyond traditional normal/abnormal dichotomies in interpreting kidney function tests 2 4.
Are current kidney function tests and equations accurate for early risk detection?
The ability of standard eGFR equations to detect early kidney dysfunction is limited, especially in individuals with normal or near-normal serum creatinine. Several studies suggest that directly measured GFR or alternative biomarkers may be required for more sensitive risk stratification.
- eGFR equations may not detect subtle changes in kidney function in early CKD or in patients with normal serum creatinine 6 10.
- Measured GFR using exogenous filtration markers offers greater accuracy in these populations but is less practical for widespread use 6 8.
- Changes to eGFR calculation methods (such as removing race coefficients) can shift risk categories for patients, but both old and new equations maintain strong predictive validity for adverse outcomes 5.
- The limitations of current eGFR testing underscore the value of the new study's percentile-based approach for early risk detection 6 10.
What is the value of combining eGFR with other markers for risk prediction?
Combining eGFR with additional biomarkers, particularly albuminuria, markedly improves the prediction of kidney failure and related outcomes. Risk equations that integrate multiple variables are validated in both general and high-risk populations.
- Albuminuria and eGFR are independent and additive predictors of progression to end-stage renal disease, acute kidney injury, and CKD 2 4 11.
- The Kidney Failure Risk Equation (KFRE), which incorporates age, sex, albuminuria, and eGFR, accurately stratifies risk and improves referral practices in primary care 4.
- Despite guideline recommendations, albuminuria testing is underutilized in patients with low-percentile eGFR, as highlighted by the new study 4 11.
- Integrating multiple markers into risk models can enable earlier and more precise interventions 2 4.
How do changes in kidney function over time inform prognosis?
Longitudinal assessment of kidney function, including the rate of eGFR decline (slope), can help predict the timing and likelihood of adverse outcomes. This approach is particularly useful for patient counseling and targeted prevention strategies.
- eGFR slope is a validated predictor of renal and cardiovascular events, especially in high-risk populations such as people with diabetes 1 13.
- Modeling changes in eGFR over time allows for personalized risk estimates and can identify patients at imminent risk for kidney failure 3 13.
- The integration of eGFR slope with other clinical variables may further refine prognostic models 3 13.
- The new study's focus on early detection complements these dynamic risk assessment strategies 1 3 13.
Future Research Questions
While the new study advances early detection of CKD risk, questions remain regarding the optimal implementation of percentile-based assessment, integration with other biomarkers, and broader application across diverse populations. Further research is needed to address these gaps and refine risk prediction tools.
| Research Question | Relevance |
|---|---|
| Does using eGFR percentiles improve chronic kidney disease outcomes compared to absolute cut-offs? | Evaluating whether percentile-based risk assessment leads to earlier intervention and better outcomes is important for updating clinical guidelines and improving patient care 2 4. |
| How can albuminuria testing be optimized for patients with low-percentile eGFR? | Since albuminuria is a strong predictor of kidney failure, understanding how to increase its use in at-risk populations may improve risk stratification and early detection 2 4 11. |
| Are percentile-based eGFR reference charts applicable across diverse ethnic and geographic populations? | Reference charts developed in one population may not translate directly to others due to demographic and biological differences, necessitating validation in broader cohorts 5. |
| What is the impact of serial eGFR measurements and eGFR slope on early intervention strategies? | Determining how dynamic changes in kidney function can guide clinical decisions may enhance the effectiveness of early intervention and monitoring strategies 1 3 13. |
| How do changes in eGFR calculation methods affect risk stratification and clinical outcomes? | Modifications to eGFR equations, including removal of race coefficients or the use of alternative markers, may influence patient classification and treatment; examining the implications is essential for practice guidelines 5 6. |
In summary, the new study reinforces growing evidence that small differences in kidney function—visible only when considering age- and sex-specific percentiles—are clinically meaningful. Integration of these approaches with albuminuria measurement, serial monitoring, and diverse risk models may represent the next step in optimizing kidney disease prevention and management.